These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27570976)

  • 1. Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data.
    Huang Y; Vemer P; Zhu J; Postma MJ; Chen W
    PLoS One; 2016; 11(8):e0159297. PubMed ID: 27570976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.
    Scalone L; Cesana G; Furneri G; Ciampichini R; Beck-Peccoz P; Chiodini V; Mangioni S; Orsi E; Fornari C; Mantovani LG
    PLoS One; 2014; 9(12):e113741. PubMed ID: 25470484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    J Diabetes Investig; 2019 Mar; 10(2):531-538. PubMed ID: 29993198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?
    Wang W; Fu CW; Pan CY; Chen W; Zhan S; Luan R; Tan A; Liu Z; Xu B
    Value Health; 2009 Sep; 12(6):923-9. PubMed ID: 19824187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Economic Burden of Type 2 Diabetes Mellitus Patients with and without Medical Insurance: A Cross-Sectional Study in China.
    Yang C; Huang Z; Sun K; Hu Y; Bao X
    Med Sci Monit; 2018 May; 24():3098-3102. PubMed ID: 29752429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical costs of managed care in patients with type 2 diabetes mellitus.
    Bhattacharyya SK; Else BA
    Clin Ther; 1999 Dec; 21(12):2131-42. PubMed ID: 10645758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory.
    Pagano E; De Rosa M; Rossi E; Cinconze E; Marchesini G; Miccoli R; Vaccaro O; Bonora E; Bruno G
    Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):944-50. PubMed ID: 27289165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of type 2 diabetes mellitus in rural southwest China.
    Le C; Lin L; Jun D; Jianhui H; Keying Z; Wenlong C; Ying S; Tao W
    Int J Cardiol; 2013 May; 165(2):273-7. PubMed ID: 21908062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data.
    Liu X; Zhang L; Chen W
    Front Public Health; 2023; 11():1062903. PubMed ID: 37143967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hospital length of stay and direct costs of type 2 diabetes in Hubei Province, China.
    Chen D; Liu S; Tan X; Zhao Q
    BMC Health Serv Res; 2017 Mar; 17(1):199. PubMed ID: 28288623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
    Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
    Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting the economic burden of type 1 and type 2 diabetes mellitus in Germany from 2010 until 2040.
    Voeltz D; Vetterer M; Seidel-Jacobs E; Brinks R; Tönnies T; Hoyer A
    Popul Health Metr; 2024 Jul; 22(1):17. PubMed ID: 39026351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.